Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trial
Juan Pablo Alderuccio, Alvaro J. Alencar, Jonathan H. Schatz, Russ Kuker, Georgios Pongas, Isildinha M. Reis, Lazaros J. Lekakis, Jay Y. Spiegel, Jose Sandoval‐Sus, Amer Beitinjaneh, Michele Stanchina, Asaad Trabolsi, Izidore S. Lossos, Joseph D. Rosenblatt, David Lessen, Craig H. Moskowitz
Topics & Concepts
MedicineRituximabFollicular lymphomaRefractory (planetary science)Internal medicineFollicular phaseLymphomaOncologyAstrobiologyPhysicsLymphoma Diagnosis and TreatmentCAR-T cell therapy researchRadiopharmaceutical Chemistry and Applications